5-(Hydroxymethyl)uracil
-
5-(Hydroxymethyl)uracil
structure -
-
CAS No:
4433-40-3
-
Formula:
C5H6N2O3
-
Chemical Name:
5-(Hydroxymethyl)uracil
-
Synonyms:
2,4(1H,3H)-Pyrimidinedione,5-(hydroxymethyl)-;Uracil,5-(hydroxymethyl)-;5-(Hydroxymethyl)-2,4(1H,3H)-pyrimidinedione;5-(Hydroxymethyl)uracil;α-Hydroxythymine;NSC 20901;5-(Hydroxymethyl)-1,3-dihydropyrimidine-2,4-dione;5-Hydroxymethyl-1H-pyrimidine-2,4-dione
- Categories:
-
CAS No:
Description
5-Hydroxymethyluracil is a product of oxidative DNA damage. 5-Hydroxymethyluracil can be used as a potential epigenetic mark enhancing or inhibiting transcription with bacterial RNA polymerase.
Solid
5-hydroxymethyluracil is a primary alcohol that is uracil bearing a hydroxymethyl substituent at the 5-position. It has a role as a human metabolite. It is a primary alcohol and a pyrimidone. It derives from a uracil.
5-(Hydroxymethyl)uracil Basic Attributes
142.11
142.11
224-636-5
590TQ3GL34
20901
DTXSID9063455
2933599090
Characteristics
78.4
-1.9
Solid
1.4±0.1 g/cm3
195-200 °C
530.4°C at 760 mmHg
274.6ºC
1.528
Soluble in water. (50 g/L ) at 20°C, DMSO, dimethyl formamide or 100% ethanol.
Refrigerator
119.21 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|142.06 Ų [M+Na]+ [CCS Type: DT, Method: stepped-field]|124.5 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|124.1 Ų [M-H]-
Safety Information
NONH for all modes of transport
3
S22-S24/25
YR0513000
Xi: Irritant;
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501
H315
|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 2 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)|Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
5-hydroxymethyluracil
5-(Hydroxymethyl)uracil Use and Manufacturing
To a mixture of 1H-pyrimidine-2, 4-dione (20 g, 178.4 mmol) in aqueous solution of potassium hydroxide (8.0 g, 142.7 mmol) in water (160.0 mL), paraformaldehyde (6.96 g, 231.9 mmol) was added portion-wise at 0° C. The resulting reaction mixture was stirred at 55° C. for 36 h. After completion, the reaction was cooled to room temperature and concentrated to A suspension of uracil (2.5 g, 22.3 mmol) and para-formaldehyde (2.0 g, 66.9 mmol) in H2O (75 mL)was treated with NEt3 (4.6 mL, 33.4 mmol) and heated with stirring at 60 °C for 16 h. The mixture wasrotary evaporated, and the residue triturated with H2O and EtOH (1:1, 20 mL), stirred for 1 h at 0 °C, filtered and washed with cold EtOH to yield 5-hydroxymethyluracil (20) (2.3 g, 73 percent) as a white solidA mixture of uracil (3.6 g, 32.1 mmol), formaldehyde (37percent in water) (3.25 ml), KOH (1.4 g, 25 mmol) in water (45 ml) was stirred at 50° C. for 20 h. The reaction was acidified with 1 N HCl to give a white precipitate. The solids were collected dried under vacuum to give the 5-(hydroxymethyl)-2, 4(1H, 3H)-pyrimidinedione (2.01 g, 44percent) as a white solid.Uracil (10.0 g, 89.2 mmol, 1.0 eq.) and paraformaldehyde (3.24 g, 107 mmol, 1.2 eq.) were treated with KOH (0.5 M, 133 ml) and the mixture heated at 50 °C for 8 hours 30 minutes, stirred at rt for 64 hours then heated at 50°C for 24 hours. The mixture was cooled to 0°C in an ice bath and acidified to pH 6 with HC1 (conc). The precipitate wasfiltered off, washed with water and oven dried providing the title compound (4.93 g, 39percent) as a white solid.‘HNMR (400 MHz, DMSO)6 11.05 (s, IH), 10.71 (s, 1H), 7.24(s, IH), 4.85 (t, J=5.5 Hz, 1H), 4.11 (dd, J 5.5, 1.1 Hz, 2H). Rf = 0.10 (50:8:1 DCM:EtOH:NH3)Intermediate 1 [00353j A 1-L, three-necked flask equipped with a mechanical stirrer, was charged with uracil (45.0 g, 401 mmol) and paraformaldehyde (14.5 g, 483 mmol). A solution of potassium hydroxide (0.5 M, 600 mL, 0.30 mol) was added in one portion. The resulting mixture was stirred at 55 °C overnight. The mixture was cooled in an ice-water bath and the pH was adjusted to 6 with 12 N HC1. The resulting precipitate was collected by filtration and dried to afford the title compound (46.0 g) as a white solid which was used in the next step without further purification. ‘H NMR (400 MHz, DMSO-d6): ö 4.12 (d, 2H), 4.78 (t, 1H), 7.24 (s, 1H), 10.64 (s, 1H), 10.98 (s, 1H).(2) Uracil (13.5 g, 100 mmol) and paraformaldehyde (4.5 g, 120 mmol) were dissolved in 150 mL of 0.5 mol / L After the potassium hydroxide solution was stirred for half an hour, it was stirred in a water bath at 52 ° C for about 20 hours. The thin layer analysis showed that the raw material completely disappeared. Most of the water is removed with a rotary evaporator so that the inner volume of the flask is approximately 1/3 of the original volume, After adding an equal amount of acetone recrystallized at 0 ~ 5 °C , 3 hours, suction filtration, washing, pumping dry, vacuum drying, weighing. Product is a white solid 16.26g
2,4(1H,3H)-Pyrimidinedione, 5-(hydroxymethyl)-: INACTIVE
Computed Properties
Molecular Weight:142.11
XLogP3:-1.9
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:1
Exact Mass:142.03784206
Monoisotopic Mass:142.03784206
Topological Polar Surface Area:78.4
Heavy Atom Count:10
Complexity:209
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of 5-(Hydroxymethyl)uracil
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
8 YRS
Business licensed Certified factoryManufactory Supplier of Biochemicals Ingredients,Vitamin Amino Acid Ingredients,Cosmestic Ingredients,Pharma Chemicals,Organic Fine Chemicals,Food Nutrient Ingredients,Natural Plant Ingredients,APIS Intermidiates,Daily Chemicals,Agricultural Chemicals,Surfactant Chemicals,Ultraviolet Absorbents,Antioxidant Ingredients,Scientific Research Chemical,Flavors and Fragrances ChemicalsInquiryCAS No.: 4433-40-3Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
(3S)-1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid
103733-66-0
-
2-Methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
1083168-84-6
-
2-iodo-2,3-dihydroinden-1-one
113021-30-0
-
2,2-DIMETHYL-N-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRIDIN-2-YL]-PROPIONAMIDE Formula
532391-30-3
-
6-Methylbenzoxazole Formula
10531-80-3
-
Methyl N-formylanthranilate Formula
41270-80-8
-
1-(4-amino-3,5-dichlorophenyl)-2-(dimethylamino)ethanol Structure
4812-69-5
-
2,5-Dihydroxy-N-(2-hydroxyethyl)benzamide Structure
61969-53-7
-
What is Benzenemethanol, α-(aminomethyl)-4-(1-methylethyl)-
91339-24-1
-
What is 5-Hydroxy-2-iodobenzaldehyde
50765-11-2
- Hot Searches
- 3-methylbutanal
- chromate charge
- propyne
- cefipime
- atelectasis symptoms
- bro2